Zobrazeno 1 - 10
of 857
pro vyhledávání: '"Jay Cho"'
Autor:
Seunghee Kim-Schulze, Sundar Jagannath, Sacha Gnjatic, Ajai Chari, Samir Parekh, Keren Osman, Selma Bekri, Hearn Jay Cho, David G Coffey, Adolfo Aleman, Simone Kats, Amishi Dhadwal, Donna Catamero
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 12, Iss 4 (2024)
Background Autologous stem cell transplantation (ASCT) after induction therapy improves disease-free survival for patients with multiple myeloma (MM). While the goal of ASCT is to render a minimal disease state, it is also associated with eradication
Externí odkaz:
https://doaj.org/article/4790a00a661e458ba2ebf32b8bdaa81f
Autor:
Joseph Han, Shayan Owji, Aneesh Agarwal, Samir Kamat, Yen Luu, Adnan Mubasher, George Niedt, Chloe Ray, Hearn Jay Cho, Nicholas Gulati, Angela Lamb
Publikováno v:
Dermatopathology, Vol 10, Iss 3, Pp 226-230 (2023)
Bortezomib is the first proteasome inhibitor to treat a variety of malignancies and is currently part of the standard of care regimen for the initial treatment of patients with newly diagnosed multiple myeloma. While bortezomib is generally well tole
Externí odkaz:
https://doaj.org/article/9dffb2d0ed9c40bab6a55d4f4000b2f9
Autor:
Aghaee, Mahya, Ledzewicz, Urszula, Robbins, Michael, Bezman, Natalie, Jay Cho, Hearn, Moore, Helen
Publikováno v:
In European Journal of Pharmaceutical Sciences 1 August 2023 187
Autor:
William Pilcher, Beena E. Thomas, Swati S. Bhasin, Reyka G. Jayasinghe, Lijun Yao, Edgar Gonzalez-Kozlova, Surendra Dasari, Seunghee Kim-Schulze, Adeeb Rahman, Jonathan Patton, Mark Fiala, Giulia Cheloni, Taxiarchis Kourelis, Madhav V. Dhodapkar, Ravi Vij, Shaadi Mehr, Mark Hamilton, Hearn Jay Cho, Daniel Auclair, David E. Avigan, Shaji K. Kumar, Sacha Gnjatic, Li Ding, Manoj Bhasin
Publikováno v:
npj Genomic Medicine, Vol 8, Iss 1, Pp 1-18 (2023)
Abstract Despite advancements in understanding the pathophysiology of Multiple Myeloma (MM), the cause of rapid progressing disease in a subset of patients is still unclear. MM’s progression is facilitated by complex interactions with the surroundi
Externí odkaz:
https://doaj.org/article/5ec9d6ffad3147ae897b03780c2b90aa
Autor:
Reed, Fred W.
Publikováno v:
Social Forces, 1982 Jun 01. 60(4), 1229-1231.
Externí odkaz:
https://www.jstor.org/stable/2577911
Autor:
Josh N. Vo, Yi-Mi Wu, Jeanmarie Mishler, Sarah Hall, Rahul Mannan, Lisha Wang, Yu Ning, Jin Zhou, Alexander C. Hopkins, James C. Estill, Wallace K. B. Chan, Jennifer Yesil, Xuhong Cao, Arvind Rao, Alexander Tsodikov, Moshe Talpaz, Craig E. Cole, Jing C. Ye, Multiple Myeloma Research Consortium, P. Leif Bergsagel, Daniel Auclair, Hearn Jay Cho, Dan R. Robinson, Arul M. Chinnaiyan
Publikováno v:
Nature Communications, Vol 13, Iss 1, Pp 1-13 (2022)
The genetic factors involved in disease progression and drug resistance in multiple myeloma (MM) are varied and complex. Here, genomic and transcriptomic profiling of 511 relapsed and refractory MM patients reveals genetic alterations in several onco
Externí odkaz:
https://doaj.org/article/f655f451b78e4e7097fa8cd313e2e43d
Autor:
Karthik Ramasamy, Ajay Nooka, Hang Quach, Myo Htut, Rakesh Popat, Michaela Liedtke, Sascha A. Tuchman, Jacob Laubach, Cristina Gasparetto, Asher Chanan-Khan, Mark Hertzberg, Mark deMario, Eveline Nueesch, Evelyne Chesne, Izolda Franjkovic, Katharina Lechner, Martin Kornacker, Hearn Jay Cho
Publikováno v:
Blood Cancer Journal, Vol 11, Iss 9, Pp 1-3 (2021)
Externí odkaz:
https://doaj.org/article/10c2cc1e770743f2a87f66ba38a6b379
Autor:
Bo Wang, Oliver Van Oekelen, Tarek H. Mouhieddine, Diane Marie Del Valle, Joshua Richter, Hearn Jay Cho, Shambavi Richard, Ajai Chari, Sacha Gnjatic, Miriam Merad, Sundar Jagannath, Samir Parekh, Deepu Madduri
Publikováno v:
Journal of Hematology & Oncology, Vol 13, Iss 1, Pp 1-12 (2020)
Abstract Background The COVID-19 pandemic, caused by SARS-CoV-2 virus, has resulted in over 100,000 deaths in the USA. Our institution has treated over 2000 COVID-19 patients during the pandemic in New York City. The pandemic directly impacted cancer
Externí odkaz:
https://doaj.org/article/2a8a134dee804d76a7bfadb029e72a2b
Autor:
Selma Bekri, Reunet Rodney-Sandy, Diana Gruenstein, Anna Mei, Bjarne Bogen, John Castle, Daniel Levey, Hearn Jay Cho
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 10, Iss 2 (2022)
Background Cancer-associated neoantigens (neoAg) derived from tumor genomic sequencing and predictive algorithms for mutated peptides are a promising basis for therapeutic vaccines under investigation. Although these are generally designed to bind ma
Externí odkaz:
https://doaj.org/article/f3e47cf491c84b1d9989d647255dd0da
Autor:
Tarek H. Mouhieddine, Oliver Van Oekelen, David T. Melnekoff, Jeanne Li, Yogita Ghodke-Puranik, Guido Lancman, Santiago Thibaud, Darren Pan, Sridevi Rajeeve, Sarita Agte, Adolfo Aleman, Larysa Sanchez, Shambavi Richard, Adriana Rossi, Joshua Richter, Hearn Jay Cho, Cesar Rodriguez, Alessandro Lagana, Erin Moshier, Ajai Chari, Sundar Jagannath, Samir Parekh
Publikováno v:
Blood Advances. 7:1056-1064
T-cell redirection therapy using chimeric antigen receptor (CAR) T cells and bispecific antibodies (BiAbs) has shown promising efficacy in heavily pretreated patients with relapsed/refractory multiple myeloma (RRMM), leading to the approval of 2 CAR
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::54a9b9e7560daf275315faf4f82da095
https://doi.org/10.1182/bloodadvances.2022007923
https://doi.org/10.1182/bloodadvances.2022007923